Oxidative stress, a hallmark of Alzheimer disease (AD), has been shown to induce lipid peroxidation and apoptosis disrupting cellular homeostasis. Normally, the aminophospholipid phosphatidylserine (PtdSer) is asymmetrically distributed on the cytosolic leaflet of the lipid bilayer. Under oxidative stress conditions, asymmetry is altered, characterized by the appearance of PtdSer on the outer leaflet, to initiate the first stages of an apoptotic process. PtdSer asymmetry is actively maintained by the ATP-dependent translocase flippase, whose function is inhibited if covalently bound by lipid peroxidation products, 4-hydroxynonenal (HNE) and acrolein, within the membrane bilayer in which they are produced. Additionally, pro-apoptotic proteins Bax and caspase-3 have been implemented in the oxidative modification of PtdSer resulting in subsequent asymmetric collapse, while anti-apoptotic protein Bcl-2 has been found to prevent this process.
Introduction
The asymmetric distribution and localization of the aminophospholipid phosphatidylserine (PtdSer) to the cytosolic leaflet of the cellular membrane is actively regulated by the ATP-dependent membrane bound aminophospholipid translocase flippase, a P-type ATPase known to transport phospholipids across the bilayer (Daleke, 2003; Paulusma and Oude Elferink, 2005; Tang et al., 1996) . In the event asymmetry is altered, PtdSer is exposed to the cell surface, initiating early stages of apoptosis considered crucial to selective recognition and mononuclear phagocytosis of target cells by macrophages and fibroblasts (Castegna et al., 2004; Fadok et al., 2001; Tyurina et al., 2004b) . Exposure of PtdSer to the outer leaflet has been noted to affect protein function involving platelet aggregation, activity of membrane receptors and transport proteins, signal transduction pathways, and cellular morphology via interference with lipidprotein and protein-protein interactions (Balasubramanian and Schroit, 2003; Paulusma and Oude Elferink, 2005; Verkleij and Post, 2000) .
Previous studies have shown that lipid peroxidation, leading to loss of phospholipid asymmetry (Castegna et al., 2004; Kagan et al., 2002; Mohmmad Abdul and Butterfield, 2005) , ultimately leads to apoptosis (Fadok et al., 1992; Kagan et al., 2003; Shimohama, 2000) . Oxidative stress and oxidative damage, hallmarks of Alzheimer disease (AD) pathology, can lead to increased production of lipid peroxidation products, 4-hydroxynonenal (HNE) and acrolein (2-propenal), in the membrane bilayer (Butterfield et al., 2001 (Butterfield et al., , 2002 Butterfield and Lauderback, 2002; Lovell et al., 2001; Markesbery and Lovell, 1998) . These reactive alkenals have been found to interfere with PtdSer asymmetry via redox dependent flippase (Castegna et al., 2004; Daleke, 2003; Tyurina et al., 2004b) . Furthermore, much evidence indicates that oxidative modification of flippase by reactive alkenals and/or apoptotic proteins, resulting in asymmetric collapse (Castegna et al., 2004; Kagan et al., 2002; Mandal et al., 2005; Mohmmad Abdul and Butterfield, 2005; Tyurina et al., 2004a) , is greatly elevated in the early apoptotic 
